KLF12 inhibits lipopolysaccharide-induced inflammatory responses, oxidative stress, pyroptosis, and endoplasmic reticulum stress in human airway epithelial cells through inhibition of the NF-κB pathway
Xiujuan Xu,
No information about this author
Yiping Yu
No information about this author
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 119917 - 119917
Published: Feb. 1, 2025
Language: Английский
KLF12 transcriptional activation by a novel LncRNA A930015D03Rik enhances melanoma metastasis
Meng Xiang,
No information about this author
Ziyi Li,
No information about this author
Jie Su
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
309, P. 142686 - 142686
Published: April 4, 2025
Language: Английский
The role of circular RNAs in regulating cytokine signaling in cancer
Vandana Joshi,
No information about this author
Swati Swati,
No information about this author
Amit Mishra
No information about this author
et al.
FEBS Open Bio,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 12, 2025
Dysregulation
of
cytokine
signaling
is
central
to
the
development
and
progression
cancer.
Cytokines
are
not
only
involved
in
promoting
cancer
but
also
regulate
anti‐tumor
immune
responses.
Circular
RNAs
(circRNAs)
single‐stranded,
covalently
closed
RNA
molecules
lacking
free
ends,
which
have
emerged
as
critical
regulators
signaling.
Transcriptional
post‐transcriptional
regulation
by
circRNAs
contributes
pathogenesis.
Here,
we
discuss
emerging
role
modulating
pathways
that
development.
In
particular,
examine
TGF‐β,
IL‐6,
IL‐10,
TNF‐α,
VEGF,
FGF,
PDGF,
chemokine
Language: Английский
Echinacoside inhibits hepatocellular carcinoma progression by targeting the miR-30c-5p/FOXD1/KLF12 axis
Guoyu Wang,
No information about this author
Yang Han,
No information about this author
Juhua Zhuang
No information about this author
et al.
Technology and Health Care,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 16
Published: Aug. 29, 2024
BACKGROUND:
Hepatocellular
carcinoma
(HCC)
is
the
third
leading
cause
of
cancer-attributed
mortality
and
primary
liver
malignancy
in
world.
Echinacoside
a
phenylethanoid
glycoside
derived
from
traditional
Chinese
medicinal
herbs
which
possessed
multiple
health
benefits
on
humans,
including
anti-tumor
effects.
OBJECTIVE:
This
study
aimed
to
demonstrate
function
echinacoside
HCC
progression
involvement
miR-30c-5p/FOXD1/KLF12
axis.
METHODS:
The
HepG2
cells
were
treated
by
different
dose
echinacoside,
miR-30c-5p
mimic,
inhibitor,
FOXD1
overexpression
lentiviruses
or
siRNA
individually
simultaneously.
cell
invasion
migration
measured
transwell
assay.
RNA
protein
levels
tested
RT-PCR
western
blot,
respectively.
regulatory
Forkhead
box
D1
(FOXD1),
Krüppel-like
factor
12
(KLF12)
was
luciferase
reporter
assay
or/and
ChIP
Meanwhile,
cancer
lung
metastasis
mice
model
used
examine
functions
vivo.
Moreover,
correlations
among
miR-30c-5p,
FOXD1,
KLF12,
prognosis
analyzed
using
clinical
sample
TCGA
database.
RESULTS:
Based
both
vitro
vivo
investigations,
we
found
that
could
inhibit
migration,
invasiveness,
tumor
metastasis,
associated
with
enhanced
Furthermore,
through
analyzing
interactions
intermediate
molecules,
revealed
KLF12üere
clinically
relevant
each
other
patients,
correlated
prognosis,
regulated
contribute
inhibition
progression.
CONCLUSIONS:
These
findings
suggest
progression,
mechanism
related
abovementioned
molecules
might
serve
as
prospective
biomarkers
for
prognosis.
Language: Английский